Lista de obras -

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

artículo científico publicado en 2011

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

artículo científico publicado en 2012

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

artículo científico publicado en 2015

2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

artículo científico publicado en 2015

2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

artículo científico publicado en 2015

Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users

artículo científico publicado en 2006

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2

artículo científico publicado en 2020

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3

artículo científico publicado en 2020

Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patients

artículo científico publicado en 2016

Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster

artículo científico publicado en 2013

Balancing benefits and risks in the era of biologics

scientific article published on 24 October 2019

Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and O

article

Biologics and heart failure in rheumatoid arthritis: are we any wiser?

artículo científico publicado en 2008

Blood transfusion, alcohol use, and anthropometric risk factors for rheumatoid arthritis in older women.

artículo científico publicado en 2002

Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.

artículo científico publicado en 2010

Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis

artículo científico publicado en 2013

Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trials

artículo científico publicado en 2011

Challenges in Improving the Quality of Osteoporosis Care for Long-term Glucocorticoid Users

scientific article published on 01 March 2007

Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: results from the Iowa Women's Health Study

artículo científico publicado en 2002

Comparison of an interactive voice response system and smartphone application in the identification of gout flares

scientific article published on 29 June 2019

Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women's Rheumatoid Arthritis Sequential Study (BRASS) Registry

scientific article published on 01 October 2020

Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial

artículo científico publicado en 2019

Developing a bone mineral density test result letter to send to patients: a mixed-methods study.

artículo científico publicado en 2014

Developing a provisional definition of flare in patients with established gout

artículo científico publicado en 2012

Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology ⬇️

artículo científico publicado en 2014

Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data

artículo científico publicado en 2012

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update ⬇️

artículo científico publicado en 2017

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

artículo científico publicado en 2020

Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)

artículo científico publicado en 2012

Effect of racial differences on ability to afford prescription medications

artículo científico publicado en 2008

Effect of self-referral on bone mineral density testing and osteoporosis treatment

artículo científico publicado en 2014

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial.

artículo científico publicado en 2009

Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo-Controlled Study

artículo científico publicado en 2019

Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW).

artículo científico publicado en 2014

Epidemiology, risk factors, and lifestyle modifications for gout

artículo científico publicado en 2006

Evaluating comorbidity scores based on health service expenditures

artículo científico publicado en 2012

Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout ⬇️

artículo científico publicado el 15 de junio de 2010

Glucocorticoid use in rheumatoid arthritis

artículo científico publicado en 2002

Glucocorticoid-induced osteoporosis: 2019 concise clinical review

scientific article published on 25 February 2019

Glucocorticoid-induced osteoporosis: from clinical trials to clinical practice

scientific article published on 20 September 2019

Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout

artículo científico publicado en 2019

Health-related quality of life in Gulf War era military personnel

artículo científico publicado en 2002

Identification and validation of vertebral compression fractures using administrative claims data

artículo científico publicado en 2009

Impact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients

artículo científico publicado en 2015

Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women

artículo científico publicado en 2010

Improving bone mineral density reporting to patients with an illustration of personal fracture risk.

artículo científico publicado en 2014

Improving osteoporosis care in high-risk home health patients through a high-intensity intervention

artículo científico publicado en 2011

Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States

artículo científico publicado en 2012

Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial

artículo científico publicado en 2019

Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study

artículo científico publicado en 2012

Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases

artículo científico publicado en 2011

Is Rheumatoid Arthritis a Cardiovascular Risk Equivalent to Diabetes?

artículo científico publicado en 2018

Is Withholding Osteoporosis Medication After Fracture Sometimes Rational? A Comparison of the Risk for Second Fracture Versus Death ⬇️

artículo científico publicado el 30 de junio de 2010

Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) study

artículo científico publicado en 2013

OMERACT endorsement of measures of outcome for studies of acute gout

artículo científico publicado en 2013

Patient-reported communications with pharmacy staff at community pharmacies: The Alabama NSAID Patient Safety Study, 2005–2007

artículo científico publicado en 2009

Physical activity measured using wearable activity tracking devices associated with gout flares

artículo científico publicado en 2020

Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender

artículo científico publicado en 2009

Potential and pitfalls of using large administrative claims data to study the safety of osteoporosis therapies.

artículo científico publicado en 2011

Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: the impact of ethnic-specific normative data.

artículo científico publicado en 2005

Prevention and treatment of bone changes associated with exposure to glucocorticoids

artículo científico publicado en 2013

RE: Drug risk assessment and data reuse

artículo científico publicado en 2014

Racial disparities in osteoporosis prevention in a managed care population

artículo científico publicado en 2003

Racial/ethnic disparities in patient-reported nonsteroidal antiinflammatory drug (NSAID) risk awareness, patient-doctor NSAID risk communication, and NSAID risk behavior

artículo científico publicado en 2007

Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment

artículo científico publicado en 2012

Rates of malignancy associated with juvenile idiopathic arthritis and its treatment

artículo científico publicado en 2012

Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs.

artículo científico publicado en 2013

Real-world bone turnover marker use: impact on treatment decisions and fracture

artículo científico publicado en 2020

Reply

scientific article published on 02 September 2019

Reply to Serious Adverse Events With Romosozumab Use in Japanese Patients: Need for Clear Formulation of Contraindications Worldwide

scientific article published on 16 April 2020

Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice

artículo científico publicado en 2012

Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy

artículo científico publicado en 2014

Serum urate and its relationship with alcoholic beverage intake in men and women: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) cohort

artículo científico publicado en 2010

Sex differences in gout epidemiology: evaluation and treatment

artículo científico publicado en 2006

Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems

artículo científico publicado en 2011

Teriparatide or alendronate in glucocorticoid-induced osteoporosis

artículo científico publicado en 2007

The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents

artículo científico publicado en 2011

The delivery of evidence-based preventive care for older Americans with arthritis

artículo científico publicado en 2010

Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases

artículo científico publicado en 2013

Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients

artículo científico publicado en 2012

Use of health plan combined with registry data to predict clinical trial recruitment.

artículo científico publicado en 2013

Validation of a definition for flare in patients with established gout

artículo científico publicado en 2017

Validation of diagnostic codes for subtrochanteric, diaphyseal, and atypical femoral fractures using administrative claims data.

artículo científico publicado en 2011

Validity of gout diagnoses in administrative data

artículo científico publicado en 2007

Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study

artículo científico publicado en 2004

Lista de obras de

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3

Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patients

Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster

Balancing benefits and risks in the era of biologics

Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and O

Biologics and heart failure in rheumatoid arthritis: are we any wiser?

Blood transfusion, alcohol use, and anthropometric risk factors for rheumatoid arthritis in older women.

Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.

Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis

Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trials

Challenges in Improving the Quality of Osteoporosis Care for Long-term Glucocorticoid Users

Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: results from the Iowa Women's Health Study

Comparison of an interactive voice response system and smartphone application in the identification of gout flares

Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women's Rheumatoid Arthritis Sequential Study (BRASS) Registry

Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial

Developing a bone mineral density test result letter to send to patients: a mixed-methods study.

Developing a provisional definition of flare in patients with established gout

Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology ⬇️

Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update ⬇️

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)

Effect of racial differences on ability to afford prescription medications

Effect of self-referral on bone mineral density testing and osteoporosis treatment

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial.

Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo-Controlled Study

Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW).

Epidemiology, risk factors, and lifestyle modifications for gout

Evaluating comorbidity scores based on health service expenditures

Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout ⬇️

Glucocorticoid use in rheumatoid arthritis

Glucocorticoid-induced osteoporosis: 2019 concise clinical review

Glucocorticoid-induced osteoporosis: from clinical trials to clinical practice

Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout

Health-related quality of life in Gulf War era military personnel

Identification and validation of vertebral compression fractures using administrative claims data

Impact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients

Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women

Improving bone mineral density reporting to patients with an illustration of personal fracture risk.

Improving osteoporosis care in high-risk home health patients through a high-intensity intervention

Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States

Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial

Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study

Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases

Is Rheumatoid Arthritis a Cardiovascular Risk Equivalent to Diabetes?

Is Withholding Osteoporosis Medication After Fracture Sometimes Rational? A Comparison of the Risk for Second Fracture Versus Death ⬇️

Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) study

OMERACT endorsement of measures of outcome for studies of acute gout

Patient-reported communications with pharmacy staff at community pharmacies: The Alabama NSAID Patient Safety Study, 2005–2007

Physical activity measured using wearable activity tracking devices associated with gout flares

Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender

Potential and pitfalls of using large administrative claims data to study the safety of osteoporosis therapies.

Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: the impact of ethnic-specific normative data.

Prevention and treatment of bone changes associated with exposure to glucocorticoids

RE: Drug risk assessment and data reuse

Racial disparities in osteoporosis prevention in a managed care population

Racial/ethnic disparities in patient-reported nonsteroidal antiinflammatory drug (NSAID) risk awareness, patient-doctor NSAID risk communication, and NSAID risk behavior

Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment

Rates of malignancy associated with juvenile idiopathic arthritis and its treatment

Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs.

Real-world bone turnover marker use: impact on treatment decisions and fracture

Reply

Reply to Serious Adverse Events With Romosozumab Use in Japanese Patients: Need for Clear Formulation of Contraindications Worldwide

Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice

Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy

Serum urate and its relationship with alcoholic beverage intake in men and women: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) cohort

Sex differences in gout epidemiology: evaluation and treatment

Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems

Teriparatide or alendronate in glucocorticoid-induced osteoporosis

The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents

The delivery of evidence-based preventive care for older Americans with arthritis

Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases